Yahoo Web Search

Search results

  1. Product portfolio. At Novartis, we reimagine medicine to improve and extend people’s lives. This includes discovering and developing breakthrough therapies, providing quality generics and biosimilars, and finding new ways to deliver these treatments to as many people as possible. Products are listed alphabetically by brand name.

  2. www.novartis.com › newsNews | Novartis

    Apr 23, 2024 · Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.

  3. www.novartis.com › about › productsProducts | Novartis

    Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.

  4. The history of Novartis traces the converging destinies of three companies: Geigy, a chemicals and dyes trading company founded in Basel, Switzerland in the middle of the 18th century; Ciba, which began producing dyes in 1859; and Sandoz, a chemical company founded in Basel in 1886.

  5. www.novartis.com › in-enNovartis

    Novartis in Society integrated Report 2023. This report covers our business, strategy and performance. It highlights progress against our ESG targets and describes how we create sustainable value for diverse stakeholders. It follows requirements of the Swiss Code of Obligations and various voluntary reporting frameworks and standards.

  6. Company at a glance. Our strategy, priorities, structure, research and development, leadership, and awards and recognition, as well as our commitment to healthcare reform, policy dialogue and responsible business practices.

  7. prod1.novartis.com › diseases › coronavirusCoronavirus | Novartis

    Novartis has been responding to the coronavirus disease (COVID-19) with safety of associates and patients globally as our primary concern. We have been also contributing to research efforts, supporting communities and ensuring stable supply and price of essential medicines.

  1. People also search for